Overall, emerging evidence shows that Ang-(1-7) is protective for both cardiovascular and metabolic outcomes in animal models, and thus may provide an alternate approach to target the RAS in obesity hypertension without eliciting the adverse side effects seen with traditional RAS inhibitors. The gene discussed is ANG; the disease is hypertensive disorder.